BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 16510592)

  • 1. Matrix metalloproteinase 26 proteolysis of the NH2-terminal domain of the estrogen receptor beta correlates with the survival of breast cancer patients.
    Savinov AY; Remacle AG; Golubkov VS; Krajewska M; Kennedy S; Duffy MJ; Rozanov DV; Krajewski S; Strongin AY
    Cancer Res; 2006 Mar; 66(5):2716-24. PubMed ID: 16510592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of immunohistochemical ERα, ERβ and ERβcx expressions in normal and neoplastic breast tissues.
    Bozkurt KK; Kapucuoğlu N
    Pathol Res Pract; 2012 Mar; 208(3):133-9. PubMed ID: 22336175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased expression of estrogen receptor beta protein in proliferative preinvasive mammary tumors.
    Roger P; Sahla ME; Mäkelä S; Gustafsson JA; Baldet P; Rochefort H
    Cancer Res; 2001 Mar; 61(6):2537-41. PubMed ID: 11289127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Collagenase-3 expression in breast myofibroblasts as a molecular marker of transition of ductal carcinoma in situ lesions to invasive ductal carcinomas.
    Nielsen BS; Rank F; López JM; Balbin M; Vizoso F; Lund LR; Danø K; López-Otín C
    Cancer Res; 2001 Oct; 61(19):7091-100. PubMed ID: 11585740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen receptor beta2 negatively regulates the transactivation of estrogen receptor alpha in human breast cancer cells.
    Zhao C; Matthews J; Tujague M; Wan J; Ström A; Toresson G; Lam EW; Cheng G; Gustafsson JA; Dahlman-Wright K
    Cancer Res; 2007 Apr; 67(8):3955-62. PubMed ID: 17440111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased estrogen receptor betacx expression during mammary carcinogenesis.
    Esslimani-Sahla M; Kramar A; Simony-Lafontaine J; Warner M; Gustafsson JA; Rochefort H
    Clin Cancer Res; 2005 May; 11(9):3170-4. PubMed ID: 15867209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen receptor beta--an independent prognostic marker in estrogen receptor alpha and progesterone receptor-positive breast cancer?
    Maehle BO; Collett K; Tretli S; Akslen LA; Grotmol T
    APMIS; 2009 Sep; 117(9):644-50. PubMed ID: 19703124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of ERalpha and ERbeta in lobular carcinoma in situ.
    Middleton LP; Perkins GH; Tucker SL; Sahin AA; Singletary SE
    Histopathology; 2007 Jun; 50(7):875-80. PubMed ID: 17543077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen receptor beta and matrix metalloproteinase 1 are coexpressed in uterine endometrium and endometriotic lesions of patients with endometriosis.
    Hudelist G; Keckstein J; Czerwenka K; Lass H; Walter I; Auer M; Wieser F; Wenzl R; Kubista E; Singer CF
    Fertil Steril; 2005 Oct; 84 Suppl 2():1249-56. PubMed ID: 16210018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PPARgamma expression in breast cancer: clinical value and correlation with ERbeta.
    Papadaki I; Mylona E; Giannopoulou I; Markaki S; Keramopoulos A; Nakopoulou L
    Histopathology; 2005 Jan; 46(1):37-42. PubMed ID: 15656884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effects of estrogen receptor beta on specific hormone-responsive gene expression and association with disease outcome in primary breast cancer.
    Lin CY; Ström A; Li Kong S; Kietz S; Thomsen JS; Tee JB; Vega VB; Miller LD; Smeds J; Bergh J; Gustafsson JA; Liu ET
    Breast Cancer Res; 2007; 9(2):R25. PubMed ID: 17428314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of estrogen receptor beta increases integrin alpha1 and integrin beta1 levels and enhances adhesion of breast cancer cells.
    Lindberg K; Ström A; Lock JG; Gustafsson JA; Haldosén LA; Helguero LA
    J Cell Physiol; 2010 Jan; 222(1):156-67. PubMed ID: 19780039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oestrogen receptors alpha and beta show different associations to clinicopathological parameters and their co-expression might predict a better response to endocrine treatment in breast cancer.
    Borgquist S; Holm C; Stendahl M; Anagnostaki L; Landberg G; Jirström K
    J Clin Pathol; 2008 Feb; 61(2):197-203. PubMed ID: 18223096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expression of ERalpha, ERbeta and PR in lobular carcinoma in situ of the breast determined using laser microdissection and real-time PCR.
    Green AR; Young P; Krivinskas S; Rakha EA; Claire Paish E; Powe DG; Ellis IO
    Histopathology; 2009 Mar; 54(4):419-27. PubMed ID: 19309393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor cell specific expression of MMP-2 correlates with tumor vascularisation in breast cancer.
    Djonov V; Cresto N; Aebersold DM; Burri PH; Altermatt HJ; Hristic M; Berclaz G; Ziemiecki A; Andres AC
    Int J Oncol; 2002 Jul; 21(1):25-30. PubMed ID: 12063545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of matrix metalloproteinases and their tissue inhibitors in ductal in situ carcinomas of the breast.
    Gonzalez LO; Corte MD; Vazquez J; Junquera S; Sanchez R; Viña A; Rodriguez JC; Lamelas ML; Vizoso F
    Histopathology; 2008 Oct; 53(4):403-15. PubMed ID: 18983606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen receptor beta expression is associated with tamoxifen response in ERalpha-negative breast carcinoma.
    Gruvberger-Saal SK; Bendahl PO; Saal LH; Laakso M; Hegardt C; Edén P; Peterson C; Malmström P; Isola J; Borg A; Fernö M
    Clin Cancer Res; 2007 Apr; 13(7):1987-94. PubMed ID: 17404078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Id4 messenger RNA and estrogen receptor expression: inverse correlation in human normal breast epithelium and carcinoma.
    de Candia P; Akram M; Benezra R; Brogi E
    Hum Pathol; 2006 Aug; 37(8):1032-41. PubMed ID: 16867866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence that estrogen receptor beta enhances MMP-13 promoter activity in HIG-82 cells and that this enhancement can be influenced by ligands and involves specific promoter sites.
    Lu T; Achari Y; Rattner JB; Hart DA
    Biochem Cell Biol; 2007 Jun; 85(3):326-36. PubMed ID: 17612627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of E-cadherin, beta-catenin, cathepsin D, gelatinases and their inhibitors in invasive ductal breast carcinomas.
    Zhang YG; DU J; Tian XX; Zhong YF; Fang WG
    Chin Med J (Engl); 2007 Sep; 120(18):1597-605. PubMed ID: 17908479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.